Company Overview of Five Prime Therapeutics, Inc.
Key Executives for Five Prime Therapeutics, Inc.
|Lewis T. Williams M.D., Ph.D.||34 Relationships||Founder, Chairman, Chief Executive Officer and President||67|
|Marc L. Belsky||No Relationships||Chief Financial Officer and Senior Vice President||61|
|Kevin P. Baker Ph.D.||No Relationships||Senior Vice President of Development Sciences||--|
|Aron Marc Knickerbocker||19 Relationships||Chief Business Officer, Executive Vice President and Director||47|
|Francis W. Sarena||No Relationships||Executive Vice President, General Counsel and Secretary||45|
|View More Key Executives|
Five Prime Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Lewis T. Williams M.D., Ph.D.||34 Relationships||Five Prime Therapeutics, Inc.||67|
|Aron Marc Knickerbocker||19 Relationships||Five Prime Therapeutics, Inc.||47|
|Franklin M. Berger CFA, BA, MA, MBA||107 Relationships||Five Prime Therapeutics, Inc.||66|
|Peder K. Jensen M.D.||44 Relationships||Five Prime Therapeutics, Inc.||61|
|Sheila Gujrathi M.D.||19 Relationships||Five Prime Therapeutics, Inc.||46|
Five Prime Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee CFA, BA, MA, MBA||Franklin M. Berger||107 Relationships||2 Executives|
|Compensation Committee M.D.||Sheila Gujrathi||19 Relationships||3 Executives|
|Nominating Committee M.D.||Peder K. Jensen||44 Relationships||2 Executives|
|Corporate Governance Committee M.D.||Peder K. Jensen||44 Relationships||2 Executives|
|Management/Organization Development Committee M.D.||Sheila Gujrathi||19 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$525.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.